🔗 Share this article

Chancellor Reeves has stated she is planning "focused measures to deal with cost of living issues" in the upcoming Budget.

During an interview with media outlets, she stated that lowering price rises is a joint duty of both the administration and the central bank.

The United Kingdom's price growth is projected to be the highest among the Group of Seven industrialized countries this calendar year and the following year.

Possible Utility Cost Measures

Sources suggest the administration could take action to reduce utility costs, for example by reducing the current 5% level of VAT applied on energy.

An additional approach is to lower some of the regulatory levies presently included in household expenses.

Fiscal Limitations and Analyst Expectations

The administration will obtain the next report from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much scope there is for these actions.

The view from most analysts is that the Chancellor will have to announce higher taxes or budget cuts in order to adhere to her voluntary fiscal targets.

Earlier on Thursday, estimates showed there was a £22bn gap for the chancellor to address, which is at the more modest range of projections.

"It is a collective task between the central bank and the administration to further reduce some of the causes of price increases," Reeves informed reporters in Washington, at the annual meetings of the International Monetary Fund and global financial institution.

Tax Commitments and Global Concerns

While a great deal of the attention has been on expected tax increases, the chancellor said the most recent figures from the OBR had not changed her commitment to campaign commitments not to increase rates on income tax, sales tax or social security contributions.

She attributed an "unpredictable world" with increasing international and commercial issues for the Budget revenue measures, likely to be directed on those "with the broadest shoulders."

Global Economic Tensions

Referring to worries about the UK's trade ties with the Asian nation she said: "The UK's security interests invariably are paramount."

Last week's announcement by Chinese authorities to tighten trade restrictions on rare earths and other materials that are key for high-technology manufacturing led US President Donald Trump to threaten an further 100% import tax on imports from China, raising the prospect of an all-out commercial conflict between the two largest economies.

The American finance chief called the Chinese action "commercial pressure" and "a global supply chain power grab."

Inquired about accepting the American proposal to join its battle with China, Reeves said she was "deeply worried" by China's actions and encouraged the Beijing authorities "not to put up barriers and restrict access."

She said the decision was "damaging for the world economy and causes additional headwinds."

"It is my opinion there are fields where we need to confront Chinese policies, but there are also significant chances to export to Chinese markets, including financial services and other areas of the economic system. We've got to maintain that equilibrium appropriate."

The Treasury chief also confirmed she was collaborating with international partners "regarding our own critical minerals plan, so that we are reduced dependence."

NHS Drug Costs and Investment

Reeves also acknowledged that the price the NHS spends on drugs could rise as a consequence of ongoing negotiations with the Trump administration and its drugs companies, in return for reduced taxes and investment.

A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either pausing or canceling projects in the United Kingdom, with several blaming the low prices they are receiving.

Last month, the government science advisor said the cost the NHS pays for medicines would need to increase to prevent businesses and drug research funding departing from the United Kingdom.

Reeves informed the BBC: "It has been observed because of the pricing regime, that medical research, innovative medicines have not been provided in the UK in the way that they are in other continental states."

"Our aim is to ensure that individuals receiving care from the NHS are can access the finest life-saving drugs in the world. And so we are examining these issues, and... looking to obtain additional investment into Britain."